BP is not a strong buy for a beginner, long-term investor at this moment. While there are positive catalysts such as optimism in leadership and potential exceptional oil trading results, the negative catalysts, including hedge fund selling, legal risks, and rising net debt, outweigh the positives. Additionally, technical indicators and proprietary trading signals do not suggest a compelling entry point.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating a positive trend. However, the MACD histogram is negative (-0.233) and contracting, suggesting weakening momentum. RSI at 70.4 is neutral, offering no clear signal. Current price is near resistance (R1: 47.727), which may limit immediate upside potential.

UBS upgraded BP to Buy, citing optimism in new CEO Meg O'Neill's leadership and potential catalysts in
Exceptional Q1 oil trading results expected due to Middle East volatility.
Analysts have raised price targets, with some projecting significant upside.
Hedge funds are selling BP stock, with a 2244.27% increase in selling activity last quarter.
Legal risks from a class action lawsuit in Kenya regarding toxic waste disposal.
Rising net debt may hinder share buyback plans and earnings growth.
In Q4 2025, revenue increased by 3.56% YoY to $47.38 billion. Net income improved significantly but remains negative at -$3.42 billion, up 74.68% YoY. EPS improved to -0.22, up 83.33% YoY. Gross margin increased to 16.21%, up 27.84% YoY. While the company shows improvement, profitability remains a concern.
Analyst sentiment is mixed but leaning positive. UBS upgraded BP to Buy with a price target of 700 GBp, citing optimism in leadership and catalysts. Wells Fargo raised its price target to $54, and Morgan Stanley upgraded BP to Overweight with a target of $49.40. However, TD Cowen downgraded its price target to $44 and maintains a Hold rating.